The normal microflora of the skin includes staphylococcal species that will induce inflammation when present below the dermis but are tolerated on the epidermal surface without initiating inflammation. Here we reveal a previously unknown mechanism by which a product of staphylococci inhibits skin inflammation. This inhibition is mediated by staphylococcal lipoteichoic acid (LTA) and acts selectively on keratinocytes triggered through Toll-like receptor 3(TLR3). We show that TLR3 activation is required for normal inflammation after injury and that keratinocytes require TLR3 to respond to RNA from damaged cells with the release of inflammatory cytokines. Staphylococcal LTA inhibits both inflammatory cytokine release from keratinocytes and inflammation triggered by injury through a TLR2-dependent mechanism. To our knowledge, these findings show for the first time that the skin epithelium requires TLR3 for normal inflammation after wounding and that the microflora can modulate specific cutaneous inflammatory responses.
a r t i c l e s All complex metazoans are colonized with a myriad of microbial organisms, a group that has been referred to as the 'microbiome'. On the skin, bacterial colonization is abundant, diverse and constant, but inflammation is undesirable and is an indication of disease. The two principal normal stimuli of inflammation are injury and infection. During infection, the detection of microbes is accomplished in part by TLRs, which are best known as stimuli of inflammation. Although the role of TLRs in response to infection is well defined, the mechanisms involving TLRs that regulate inflammation in the skin injury are poorly understood.
Epithelial surfaces in the gut regulate the magnitude and duration of TLR signaling, thus shaping and maintaining normal mucosal immunity 1-3 via the induction of proinflammatory and anti-inflammatory cytokine synthesis 4, 5 . Moreover, the commensal bacteria Lactococcus lactis and Bacteroides vulgatus can prime the host to produce interleukin-10 (IL-10), trefoil factors and transforming growth factor-β (TGF-β), which are suggested to modulate inflammation in the intestine [6] [7] [8] . However, TLRs that have been generally thought to act as proinflammatory signals in response to microbial products also may recognize self-epitopes that are released from damaged cells or are present at the surface of apoptotic cells in autoimmune diseases 9, 10 . These observations have raised the possibility that TLRs may have a role in initiating inflammation in response to injury 11,12 . In skin injury, tissue damage results in necrosis and apoptosis, but it is not known if this event is involved in the initiation of the inflammatory response that is crucial to normal wound repair. In the absence of infection, uncontrolled inflammation during wound repair is undesirable and may cause dysfunction during healing. Uncontrolled inflammation after minor trauma is also well known to exacerbate several human skin diseases, such as psoriasis. Therefore, normal immune defense requires that a balance is maintained to minimize unnecessary inflammation yet rapidly respond to infection and injury. This balance is particularly difficult to maintain at epithelial surfaces that are in contact with the external environment and have frequent trauma and exposure to the products of the microbiome. The innate systems that enable the control of this inflammatory response are generally unknown.
Given the hypothesis that epithelial flora may serve to protect the host from unintended inflammatory diseases and the importance of TLRs in the recognition of microbial products and potential role after tissue damage, we set out to study how these systems may be involved in homeostatic control of skin inflammation. Staphylococcal species are the most frequently cultured normal inhabitants of the healthy human skin 13 and have been hypothesized to serve a role in human health 14 . It has been entirely unknown how these bacteria might affect cutaneous homeostasis. In this study, we describe a mechanism by which a product of staphylococci, LTA, suppresses skin inflammation during wound repair. volume 15 | number 12 | december 2009 nature medicine a r t i c l e s of proinflammatory cytokines in the epidermis as an element in the pathogenesis of some skin diseases [15] [16] [17] . However, despite production of TLR ligands, commensal bacterial species, including Staphylococcus epidermidis, normally reside in contact with keratinocytes in the epidermis and do not initiate inflammation. We therefore hypothesized that S. epidermidis can influence the inflammatory response of keratinocytes through negative regulation of TLR signaling. Primary human keratinocytes treated with a panel of TLR ligands showed that polyriboinosinic polyribocytidylic acid (poly(I:C)), a stimulus for TLR3 (ref. 18, 19) , was the most potent stimulus for expression of tumor necrosis factor-α (TNF-α) by keratinocytes and that previous exposure to a <10-kDa product of S. epidermidis suppressed poly(I:C)-induced IL-6 and TNF-α expression ( Fig. 1a and Supplementary Fig. 1a ). This suppression persisted over time and affected both messenger RNA and protein levels of TNF-α ( Supplementary Fig. 1b) .
We next examined cutaneous inflammation induced by poly(I:C) in mice to determine the in vivo relevance of the response observed to S. epidermidis. Ears pretreated with the <10-kDa product of S. epidermidis before poly(I:C) showed less inflammation compared to those treated only with poly(I:C) ( Fig. 1b,c) . The decrease in inflammation corresponded with a decrease in the expression of IL-6 and TNF-α mRNA ( Fig. 1d ). However, we did not observe the inhibitory effects of S. epidermidis <10-kDa product in whole skin when inflammation was induced by lipopolysaccharide (LPS) ( Supplementary Fig. 1c ), or phorbol 12-myristate 13-acetate (PMA) ( Supplementary Fig. 1d ). Thus, these data show that a product of S. epidermidis functions as a selective suppressor of poly(I:C)-mediated inflammation in the skin.
Analysis of similar soluble <10-kDa products of other staphylococcal strains showed that the capacity to inhibit poly(I:C)-induced TNF-α expression was present in multiple staphylococcal strains, except one hospital-isolated strain of Staphylococcus aureus (Supple mentary Fig. 2) . The <10-kDa product of S. epidermidis also suppressed the expression of IL-8 but was not able to suppress interferon-β (IFN-β) or IL-1β (data not shown). Moreover, the <10-kDa product of S. epidermidis inhibited the capacity of mouse epidermal sheets to express TNF-α and IL-6 in response to poly(I:C) ( Supplementary  Fig. 3a ). However, in contrast to keratinocytes and epidermal sheets, other cell types representative of those present in skin but below the epidermis were not inhibited by the <10-kDa product of S. epidermidis and had increased expression of IL-6 and TNF-α in response to poly(I:C) and S. epidermidis (Supplementary Fig. 3b-d) . Taken together, these results show poly(I:C) is a potent stimulus to release proinflammatory cytokines in the skin, but a soluble, low-molecular-weight product from some bacteria will inhibit this response selectively in keratinocytes.
TLR3 mediates a response to injury
To understand the immunological relevance of suppression of TLR3-induced cytokine release by keratinocytes, we next sought to investigate conditions in which TLR3 might be activated in skin. In gastrointestinal epithelium, TLR3 has been implicated as a mechanism for detection of cell death 20 . Skin injury results in the generation of necrotic and apoptotic cells 21, 22 . Therefore, we examined whether TLR3 activation might be a mechanism for detection of skin injury and initiation of inflammation. To test this hypothesis, we made aseptic, full-thickness incisions on the backs of Tlr3-deficent mice and matched wild-type controls. Tlr3-deficent mice showed significantly less production of IL-6 and TNF-α at the wound edge compared to wild-type controls ( Fig. 2a) . This correlated with a decrease in inflammation and leukocyte recruitment ( Fig. 2b and Supplementary Fig. 4 ). Furthermore, consistent with the inhibitory effects of S. epidermidis on poly(I:C)-induced skin inflammation, application of the <10-kDa product of S. epidermidis also inhibited wound-induced IL-6, TNF-α and inflammation in wild-type mice but had no marked effect on the injury response in Tlr3 −/− mice ( Fig. 2a,b and Supplementary Fig. 4 ). Thus, these findings establish that Tlr3 is required for part of the normal inflammatory response after injury and that S. epidermidis acts on this pathway to decrease the magnitude of inflammation.
Wounding results in the rapid generation of abundant amounts of damaged cells, including necrotic and apoptotic keratinocytes. To test whether a product of damaged keratinocytes can stimulate TLR3dependent inflammation in adjacent normal cells, we treated cultured human keratinocytes with ultraviolet B (UVB) radiation to induce apoptosis and cell death. We then collected these cells (UVR cells) and added them to separate cultures of normal human keratinocytes. TNF-α release significantly increased when we exposed normal keratinocytes to UVR cells but not when we exposed them to equal amounts of sonicated, nonirradiated cells ( Fig. 2c and Supplementary Fig. 5a ). This response was dependent on TLR3, as targeted knockdown of a r t i c l e s TLR3 by siRNA abrogated the response to UVR cells ( Fig. 2c and Supplementary Fig. 6 ). Consistent with the response to poly(I:C) or wounding, the <10-kDa product of S. epidermidis also inhibited TNF-α release induced by UVR cells (Fig. 2d) . The product of UVR cells that activated TLR3 in normal keratinocytes was RNA, as RNase abrogated the capacity of UVR cells to stimulate the production of TNF-α, but treatment with DNase did not ( Fig. 2e) . We also sorted UVR cells into intact, annexin V + cells that excluded propidium iodide and dead cells whose membrane was permeable after UVB irradiation and thus stained with propidium iodide. Nonirradiated cells (normal cells) disrupted by sonication, or early apoptotic cells that were annexin V-positive but excluded propidium iodide (annexin V-positive, propidium iodide-negative cells), could not induce TNF-α release or TLR3 expression ( Supplementary Fig. 5a,b) . However, UVR cells staining with propidium iodide (propidium iodidepositive cells) substantially increased TNF-α release and TLR3 expression ( Supplementary Fig. 5a,b) . Thus, these results show that RNA released from necrotic cells can induce TNF-α and TLR3 expression in keratinocytes.
LTA suppresses TLR3 inflammation TLR-TLR cross-talk can suppress inflammatory responses 23, 24 , and LTA is a known molecular signal for recognition of staphylococci; thus, we sought to determine whether this molecule might be responsible for the observed effects. LTA from S. epidermidis has two forms, cellular and exocellular LTA 25 . Exocellular LTA can be recovered from liquid growth medium and is the form present in the <10-kDa product of S. epidermidis, whereas commercial LTA is derived from the cell wall and membrane. Commercially available LTA from S. aureus (LTA-SA), but not LPS or flagellin, suppressed the production of TNF-α induced by poly(I:C) ( Fig. 3a) . LTA directly purified from S. epidermidis (LTA-SE) or commercial LTAs from some other staphylococcal species suppressed poly(I:C)-induced TNF-α, whereas other ligands of TLR2 either synergistically induced TNF-α or failed to suppress TNF-α when combined with poly(I:C) ( Fig. 3b) . 3b) . We next confirmed the identity of LTA as the molecule in S. epidermidis responsible for suppression of keratinocyte TNF-α production by use of a specific LTA-neutralizing antibody 25 (Fig. 3c) . Furthermore, synthetic LTAs containing two or three d-alanines suppressed poly(I:C)-induced TNF-α, whereas synthetic LTAs only containing an anchor or containing two or five N-acetylglucosamine failed to suppress TNF-α ( Fig. 3d) . We then confirmed the necessity of d-alanine modification by using LTA from a S. aureus dltA mutant that lacks d-alanine modifications 26 . Preparations from this mutant bacterial culture supernatant (SA dltA) partially lost the capacity to suppress poly(I:C)-induced TNF-α compared to its parental strain (Fig. 3e) .
N-TRAF1 mediates LTA inhibition of TLR3
We observed that S. epidermidis blocked nuclear translocation of the p50 subunit of nuclear factor-κB1, but not the translocation of interferon regulatory factor-3, both stimulated by poly(I:C) in keratinocytes ( Supplementary Fig. 7a,b) . Thus, we next investigated negative regulators involved in TLR-mediated NF-κB signaling, including TNF receptor-associated factor-1 (TRAF1), TNF-α-induced protein-3 (TNFAIP3) and interleukin-1 receptor-associated kinase M (IRAK-M) 27 . LTA and the <10-kDa product of S. epidermidis significantly induced TRAF1 protein and mRNA in keratinocytes within 1 h and maximally between 6 and 9 h ( Fig. 4a and Supplementary Fig. 8a) . The expression of other negative regulatory genes such as nucleotide-binding domain (NBD)-and leucine-rich-repeat (LRR)-containing family member X1 (NLRX1), TNFAIP3 or IRAK3 (encoding IRAK-M) involved in both the NF-κB and retinoic acid-inducible gene (RIG)like helicase pathways, were not induced (Supplementary Fig. 8a) . We confirmed the role of TRAF1 as a mediator of the LTA inhibitory effect by experiments in Traf1 −/− mice where LTA was unable to suppress the production of IL-6 and TNF-α at wound edge compared to wild-type controls (Fig. 4b) . It has been hypothesized that TRAF1 is processed by caspase-8 to an active N-terminal fragment (N-TRAF1) followed by binding to TRIF to serve as a negative regulator of TLR3. We observed the cleavage of TRAF1 to N-TRAF1 in the presence of the <10-kDa product of S. epidermidis and poly(I:C) (Fig. 4c) , and it occurred in a caspase-8-dependent manner, as treatment with a caspase-8 inhibitor blocked the generation of N-TRAF1 (Fig. 4d) . We found that TRAF1 associated with TRIF by immunoprecipitation of S. epidermidis-treated keratinocytes with TRAF1-specific antibody and detection with antibody to TRIF (Supplementary Fig. 8b) . Furthermore, addition of a caspase-8 inhibitor increased TNF-α production and completely abrogated the inhibitory effects of S. epidermidis and LTA (Supplementary Fig. 8c,d) .
TLR2 inhibits TLR3
Having established the involvement of TRAF1 in the suppression of keratinocyte cytokine release, and the role of the TLR2 ligand LTA in initiating this effect, we next sought to further confirm the mechanism and physiological relevance of these observations in vivo. Analysis of the skin from germ-free wild-type mice that were never exposed to bacterial products showed that the expression of Traf1 in their skin was markedly decreased compared to skin of normal mice housed in pathogen-free but nonsterile conditions (Fig. 4e) . In addition to that in skin, the expression of Traf1 in small intestine and lung, but not in heart, of germ-free wild-type mice was decreased compared to those tissues from conventional wild-type mice (Supplementary Fig. 8e ). Furthermore, because recognition of LTA requires TLR2 and the downstream adapter protein myeloid differentiation factor-88 (MYD88), we also observed diminished expression of Traf1 in Tlr2 −/− or Myd88 −/− mice exposed to LTA (Fig. 4f) . Therefore, Tlr2 −/− mice might be used as another model to test the effect of diminished Traf1 on suppression of Tlr3-dependent skin inflammation after injury. As expected, LTA failed to suppress inflammation and the production of IL-6 and TNF-α at wound (Fig. 5a,b) , and we observed a similar loss of responsiveness to LTA in Tlr2 −/− mice treated with poly(I:C) ( Fig. 5c) .
DISCUSSION
Commensal microorganisms have been proposed to influence host immune responses and host-pathogen interactions in the gut 28 . Here we hypothesized that specific elements of the resident microbiota of normal human skin can modulate cutaneous immune responses triggered by TLR ligands. Our results confirmed this hypothesis while also revealing that TLR3 is a key element in the induction of inflammation after skin injury. Inhibition of this inflammatory event is accomplished by specific staphylococcal LTAs and is mediated by TLR2 on keratinocytes. The mechanism for LTA-TLR-mediated suppression of TLR3 signaling is by induction of the negative regulatory factor TRAF1, an event we show has a major role in limiting the extent of cutaneous inflammation. Thus, we show that a sensitive balance exists between stimulating and inhibitory mediators during wound healing and that epithelial cells uniquely detect these signals to achieve tissue homeostasis after injury. It was previously unclear why keratinocytes are highly sensitive to TLR3 ligands, as the classical ligand for TLR3, viral double-stranded RNA, is not a frequent initiator of major inflammatory responses in the skin. The epidermis can be exposed to double-stranded RNA from viral infections, but such infections are relatively uncommon compared to infections by other skin pathogens. We show here that the high sensitivity to TLR3 ligands is probably because the epidermis uses TLR3 for recognition of injury to self. Our data show that RNA from necrotic cells triggers TLR3 on undamaged keratinocytes, leading to a local release of proinflammatory cytokines. This is probably a frequent mechanism for detection of injury and maintenance of homeostasis, as necrotic cells are abundant at the wound edge. Therefore, it is reasonable to speculate that TLR3 in the normal epidermis is an important sensor of injury and that systems must exist to modulate this response to prevent excessive or unwanted inflammation. Furthermore, given that S. epidermidis or LTA not only inhibited proinflammatory cytokine production by isolated keratinocytes in culture but also inhibited inflammation in vivo, the production of proinflammatory cytokines by keratinocytes is probably a major contributor to some forms of skin inflammation.
Our findings show that LTA produced by staphylococcal species have a unique anti-inflammatory action on keratinocytes. In contrast, LTA initiates the opposite response when exposed to other immune cells. It is logical that LTA would have distinct effects on cytokine release depending on the cell type exposed. LTA acts as a proinflammatory factor for cells that normally exist in a sterile environment, such as macrophages ( Supplementary Fig. 3b ), monocytes and mast cells 29, 30 . These cells are not normally exposed to the surface microbiome and appropriately recognize LTA as foreign. However, keratinocytes are unique in that they are frequently exposed to LTA. Furthermore, the structure of LTA seems to determine the nature of the keratinocyte response. Addition of d-alanine to the LTA core seemed to be a key factor in dictating activity, but further analysis is necessary to understand these LTA structure-function relationships. Moreover, other TLR2 ligands that depend on formation of a heterodimer with TLR1 or TLR6 do not inhibit TLR3 in keratinocytes but rather have a proinflammatory effect. Thus, the specificity of the response is dictated by cell type and the specific structure of the TLR2 ligand produced by the microbe. In particular, S. epidermidis, a normal inhabitant of the skin, may have a uniquely structured TLR2 ligand that maximizes anti-inflammatory action yet minimizes the capacity to initiate inflammation.
To limit TLR-induced inflammation, several negative regulatory systems exist, including sequestration of signaling molecules, blockade of their recruitment, degradation of target proteins and inhibition of transcription 27, 31 . These negative regulators can be part of microbial virulence. Examples of TLR inhibition by microbes include decoy receptors in some bacterial infections that prevent a direct interaction between TLRs and their microbial ligands, and vaccinia virus production of several proteins that interfere with viral recognition through both TLR3 and helicases [32] [33] [34] . Therefore, there is potential for pathogenic staphylococci such as S. aureus to exploit suppression of keratinocyte activation as a mechanism of virulence, whereas S. epidermidis may benefit the host by dampening unwanted inflammation. This hypothesis requires further testing but is supported by the data we obtained from germ-free mice that shows such mice lack normal expression of Traf1 in the skin. These observations support additional findings that the ability of TLR2 to recognize commensal bacteria is not irrelevant under normal conditions. Rather, activation of TLR2 in keratinocytes has its own beneficial effect in maintaining homeostasis.
Taken together, these findings are best appreciated when one recognizes that inflammation is an undesirable condition on skin but is fundamentally a necessary protective response after injury. Prolonged and dysregulated production of inflammatory cytokines leads to excessive neutrophil influx, resulting in sustained inflammatory responses and poor healing, subsequently causing extensive tissue damage 35, 36 . In contrast, without an appropriate inflammatory response, wound a r t i c l e s healing is also delayed, and the host is more susceptible to microbial invasion. Local modulation of the inflammatory response by products of bacterial commensals at the site of such an injury might be a beneficial therapeutic strategy for management of wound healing complicated by excessive inflammation or control of other inflammatory skin disorders. The trick will be to evoke a reduction in the detrimental aspects of inflammation without increasing the risk of wound infection. Our findings emphasize the potential benefit of the resident bacteria on skin and the potential negative consequences of complete depletion of microflora from skin by indiscriminate use of topical and systemic antibiotics.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
